Departments of Anaesthesia and Intensive Care, Helsinki University Hospital, Finland.
Acta Anaesthesiol Scand. 2010 Nov;54(10):1164-78. doi: 10.1111/j.1399-6576.2010.02309.x.
Management of post-partum haemorrhage (PPH) involves the treatment of uterine atony, evacuation of retained placenta or placental fragments, surgery due to uterine or birth canal trauma, balloon tamponade, effective volume replacement and transfusion therapy, and occasionally, selective arterial embolization. This article aims at introducing pregnancy- and haemorrhage-induced changes in coagulation and fibrinolysis and their relevant compensatory mechanisms, volume replacement therapy, optimal transfusion of blood products, and coagulation factor concentrates, and briefly cell salvage, management of uterine atony, surgical interventions, and selective arterial embolization. Special attention, respective management, and follow-up are required in women with bleeding disorders, such as von Willebrand disease, carriers of haemophilia A or B, and rare coagulation factor deficiencies. We also provide a proposal for practical instructions in the treatment of PPH.
产后出血(PPH)的处理包括治疗子宫收缩乏力、清除滞留的胎盘或胎盘碎片、因子宫或产道创伤而进行的手术、球囊填塞、有效容量替代和输血治疗,以及偶尔的选择性动脉栓塞。本文旨在介绍妊娠和出血引起的凝血和纤溶变化及其相关的代偿机制、容量替代治疗、最佳的血液制品和凝血因子浓缩物输注,以及简要的细胞回收、子宫收缩乏力的处理、手术干预和选择性动脉栓塞。对于患有出血性疾病(如血管性血友病、血友病 A 或 B 携带者以及罕见的凝血因子缺乏症)的女性,需要特别注意、相应的管理和随访。我们还为 PPH 的治疗提供了实用指导建议。